Exploration of visual function evaluation methods and clinical endpoints in patients with ultra-low vision - Exploration of visual function evaluation methods and clinical endpoints in patients with ultra-low vision

Keio University school of Medicine0 sites65 target enrollmentMay 16, 2022

Overview

No summary available.

Registry

who.int

Start Date

May 16, 2022

End Date

March 31, 2026

Last Updated

2 years ago

Study Type

Observational

Sex

All

Sponsor

•1\. Healthy people with other eye complications that significantly affect visual field or visual acuity, and with abnormal findings detected by slit\-lamp microscopy, fundoscopy, OCT. 2\. Those who underwent eye surgery within 3 months. 3\. Subjects who have with a history of allergy to the agents to be used in this study, e.g. mydriatic agent, anesthetic agent, etc. 4\. Subjects who are diagnosed with dementia or mental illness. 5\. Those who are pregnant or lactating. 6\. Those who are currently participating in other clinical trials. 7\. Those who have participated in a clinical trial for therapeutic purposes within the past 3 months. 8\. Those who with a history or suspected or confirmed diagnosis of alcohol or other drug addictions. 9\. Those who unable to understand the evaluation and examination procedures. 10\. Those who, in the judgment of the principal investigator, are considered to be at risk of becoming ineligible for the study. 11\. Those who are judged by the principal investigator or other investigators to be inappropriate for participation in this study.